Pessin Award Lecture 2008: Lessons from the Stroke PROTECT program

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[2]  L. Schwamm,et al.  Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get With The Guidelines" program. , 2008, Archives of internal medicine.

[3]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[4]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[5]  H. Bang,et al.  Statin treatment and adherence to national cholesterol guidelines after ischemic stroke , 2006, Neurology.

[6]  Irene Katzan,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Stroke.

[7]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[8]  R. Kothari,et al.  Lipid Testing and Lipid-Lowering Therapy in Hospitalized Ischemic Stroke and Transient Ischemic Attack Patients: Results From a Statewide Stroke Registry , 2006, Stroke.

[9]  J. Saver,et al.  Treatment Adherence Rates One Year after Initiation of a Systematic Hospital-Based Stroke Prevention Program , 2005, Cerebrovascular Diseases.

[10]  S. Johnston,et al.  Antihypertensive Medications Prescribed at Discharge After an Acute Ischemic Cerebrovascular Event , 2005, Stroke.

[11]  A. Demchuk,et al.  Silent ischemia in minor stroke and TIA patients identified on MR imaging , 2005, Neurology.

[12]  Joseph P Broderick,et al.  Acute Stroke Care in the US: Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry , 2005, Stroke.

[13]  J. Saver,et al.  In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up , 2004, Stroke.

[14]  J. Saver,et al.  PROTECT: A coordinated stroke treatment program to prevent recurrent thromboembolic events , 2004, Neurology.

[15]  R. Sacco,et al.  Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[16]  Marc B Blatt.  In-hospital initiation of lipid-lowering therapy. , 2004, Critical pathways in cardiology.

[17]  C. Anderson,et al.  Ten-Year Risk of First Recurrent Stroke and Disability After First-Ever Stroke in the Perth Community Stroke Study , 2004, Stroke.

[18]  P. Rothwell,et al.  Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services , 2004, BMJ : British Medical Journal.

[19]  C. Anderson,et al.  Ten-Year Survival After First-Ever Stroke in the Perth Community Stroke Study , 2003, Stroke.

[20]  J. Saver,et al.  Annual Incidence of First Silent Stroke in the United States: A Preliminary Estimate , 2003, Cerebrovascular Diseases.

[21]  G. Hankey.  Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack , 2003, Cerebrovascular Diseases.

[22]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[23]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[24]  S. Straus,et al.  New evidence for stroke prevention: scientific review. , 2002, JAMA.

[25]  G. Fonarow.  Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis , 2002, Vascular medicine.

[26]  S. Blankenberg,et al.  [Manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis]. , 2002, Medizinische Klinik.

[27]  Jürgen Meyer,et al.  Manifestationen der Atherosklerose in verschiedenen Gefäßregionen Gemeinsamkeiten und Unterschiede hinsichtlich Epidemiologie, Ätiologie und Prognose , 2002, Medizinische Klinik.

[28]  A. Qureshi,et al.  Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey. , 2001, Archives of internal medicine.

[29]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[30]  Valentin Fuster,et al.  Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences , 2001, Annals of Internal Medicine.

[31]  B. Horne,et al.  Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. , 2001, The American journal of cardiology.

[32]  C. Benesch,et al.  Stroke prevention , 2000, Neurology.

[33]  T. Pearson,et al.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. , 2000, Archives of internal medicine.

[34]  K. Labresh,et al.  Get with the guidelines. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  R. Grilli.  Media have key role in shaping use of health services , 1999, BMJ.

[36]  A. Folsom,et al.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.

[37]  L. Caplan.  Prevention of strokes and recurrent strokes , 1998, Journal of neurology, neurosurgery, and psychiatry.

[38]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[39]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[40]  Joyce A. Mitchell,et al.  The clinical value of computerized information services. A review of 98 randomized clinical trials. , 1996, Archives of family medicine.

[41]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[42]  S B Soumerai,et al.  Principles of educational outreach ('academic detailing') to improve clinical decision making. , 1990, JAMA.

[43]  J. Saver,et al.  In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. , 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[44]  J. Saver,et al.  Ensuring management of vascular risk factors after stroke. , 2006, Reviews in neurological diseases.

[45]  Audit and feedback versus alternative strategies: Effects on professional practice and health care outcomes (Cochrane review) , 2001 .

[46]  P. Wolf,et al.  Risk factors and their management for stroke prevention: outlook for 1999 and beyond. , 1999, Neurology.

[47]  P. Gorelick.  Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal. , 1997, Neuroepidemiology.